Two Sigma Securities, LLC Acorda Therapeutics Inc Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.55 - $1.0 $4,682 - $8,513	-8,513 Reduced 5.69%	141,152 $83,000
Q4 2022 Feb 14, 2023	BUY	$0.52 - $0.77 $65,930 - $97,627	126,789 Added 554.24%	149,665 $115,000
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.53 $1,396 - $2,552	-4,816 Reduced 17.39%	22,876 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.3 - $1.67 $8,307 - $46,245	27,692 New	27,692 $13,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.